|
| | Issue Date | Title | Contributor(s) | Type | Cat. |
| 41 | 2020 | Disability accrual in primary-progressive & secondary-progressive multiple sclerosis | Harding-Forrester, S.; Roos, I.; Sharmin, S; Diouf, I.; Malpas, C.; Nguyen, A. -L.; Moradi, N.; Horakova, D.; Havrdova, E. Kubala; Patti, F.; Izquierdo, G.; Eichau, S.; Prat, A.; Girard, M.; Duquette, P.; Onofrj, M.; Lugaresi, A.; Grand'Maison, F.; Weinstock-Guttman, B.; Amato, M. P.; Grammond, P.; Gerlach, O.; Ozakbas, S.; Sola, P.; Ferraro, D.; Butzkueven, H.; Lechner-Scott, J.; Boz, C.; Alroughani, R.; Van Pesch, V.; Cartechini, E.; Terzi, M.; Maimone, D.; Ramo-Tello, C.; Spitaleri, D.; Kappos, L.; Yamout, B.; Sa, M.; Slee, M.; Blanco, Y.; Bergamaschi, R.; Butler, E.; Iuliano, G.; Granella, F.; Sidhom, Y.; Gouider, R.; Ampapa, R.; VAN WIJMEERSCH, Bart; Karabudak, R.; Prevost, J.; Sanchez-Menoyo, J. L.; Verheul, F.; Mccombe, P.; Castillo-Trivino, T.; Macdonell, R.; Altintas, A.; Laureys, G.; Van Hijfte, L.; Van der Walt, A.; Vucic, S.; Turkoglu, R.; Barnett, M.; Cristiano, E.; Zakaria, M.; Shaygannejad, V.; Hodgkinson, S.; Soysal, A.; Kalincik, T. | Journal Contribution | M |
| 42 | 2020 | Ocrelizumab phase iiib efficacy from casting: 2-year neda (mri re-baselined) subgroup rates in rrms patients with a suboptimal response to prior dmts | Wiendl, H.; Comi, G.; Oreja-Guevara, C.; Siva, A.; VAN WIJMEERSCH, Bart; Wuerfel, J.; Buffels, R.; Kadner, K.; Kuenzel, T.; Vermersch, P. | Journal Contribution | M |
| 43 | 2020 | Delay from treatment start to full effect of immunotherapies for multiple sclerosis | Roos, Izanne; Leray, Emmanuelle; Frascoli, Federico; Casey, Romain; Brown, J. William L.; Horakova, Dana; Havrdova, Eva K.; Trojano, Maria; Patti, Francesco; Izquierdo, Guillermo; Eichau, Sara; Onofrj, Marco; Lugaresi, Alessandra; Prat, Alexandre; Girard, Marc; Grammond, Pierre; Sola, Patrizia; Ferraro, Diana; Ozakbas, Serkan; Bergamaschi, Roberto; Sa, Maria Jose; Cartechini, Elisabetta; Boz, Cavit; Granella, Franco; Hupperts, Raymond; Terzi, Murat; Lechner-Scott, Jeannette; Spitaleri, Daniele; Van Pesch, Vincent; Soysal, Aysun; Olascoaga, Javier; Prevost, Julie; Aguera-Morales, Eduardo; Slee, Mark; Csepany, Tunde; Turkoglu, Recai; Sidhom, Youssef; Gouider, Riadh; VAN WIJMEERSCH, Bart; McCombe, Pamela; Macdonell, Richard; Coles, Alasdair; Malpas, Charles B.; Butzkueven, Helmut; Vukusic, Sandra; Kalincik, Tomas | Journal Contribution | A1 |
| 44 | 2020 | CNS delivery of anti-CD52 antibodies modestly reduces disease severity in an animal model for multiple sclerosis | BOGIE, Jeroen; GRAJCHEN, Elien; WOUTERS, Elien; BROUX, Bieke; STINISSEN, Piet; VAN WIJMEERSCH, Bart; HENDRIKS, Jerome | Journal Contribution | A1 |
| 45 | 2020 | The use of alemtuzumab in patients with relapsing-remitting multiple sclerosis: the Gulf perspective | Alroughani, Raed; VAN WIJMEERSCH, Bart; Al Khaboori, Jabber; Alsharoqi, Isa Ahmed; Ahmed, Samar F.; Hassan, Ali; Inshasi, Jihad; Krieger, Derk W.; Shakra, Mustafa; Shatila, Ahmed Osman; Szolics, Miklos; Khallaf, Mohamed; Ezzat, Aly | Journal Contribution | A1 |
| 46 | 2020 | Immune thrombocytopenia in alemtuzumab-treated MS patients: Incidence, detection, and management | Cuker, Adam; Bass, Ann D.; Nadj, Congor; Agius, Mark A.; Steingo, Brian; Selmaj, Krzysztof W.; Thoits, Timothy; Guerreiro, Alexandre; VAN WIJMEERSCH, Bart; Ziemssen, Tjalf; Meuth, Sven G.; LaGanke, Christopher C.; Thangavelu, Karthinathan; Rodriguez, Claudio E.; Baker, Darren P.; Margolin, David H.; Jannsens, Ann | Journal Contribution | A1 |
| 47 | 2020 | Lymphocyte pharmacodynamics are not associated with autoimmunity or efficacy after alemtuzumab | Wiendl, Heinz; Carraro, Matthew; Comi, Giancarlo; Izquierdo, Guillermo; Kim, Ho Jin; Sharrack, Basil; Tornatore, Carlo; Daizadeh, Nadia; Chung, Luke; Jacobs, Alan K.; Hogan, Richard J.; Wychowski, Linda V.; VAN WIJMEERSCH, Bart | Journal Contribution | A1 |
| 48 | 2020 | Efficacy and Safety of Alemtuzumab Through 9 Years of Follow-up in Patients with Highly Active Disease: Post Hoc Analysis of CARE-MS I and II Patients in the TOPAZ Extension Study | Ziemssen, Tjalf; Bass, Ann D.; Berkovich, Regina; Comi, Giancarlo; Eichau, Sara; Hobart, Jeremy; Hunter, Samuel F.; LaGanke, Christopher; Limmroth, Volker; Pelletier, Daniel; Pozzilli, Carlo; Schippling, Sven; Sousa, Livia; Traboulsee, Anthony; Uitdehaag, Bernard M. J.; VAN WIJMEERSCH, Bart; Choudhry, Zia; Daizadeh, Nadia; Singer, Barry A. | Journal Contribution | A1 |
| 49 | 2020 | Efficacy of alemtuzumab over 6 years in relapsing–remitting multiple sclerosis patients who relapsed between courses 1 and 2: Post hoc analysis of the CARE-MS studies | VAN WIJMEERSCH, Bart; Singer, Barry A.; Boster, Aaron; Broadley, Simon; Fernandez, Oscar; Freedman, Mark S.; Izquierdo, Guillermo; Lycke, Jan; Pozzilli, Carlo; Sharrack, Basil; Steingo, Brian; Wiendl, Heinz; Wray, Sibyl; Ziemssen, Tjalf; Chung, Luke; Margolin, David H.; Thangavelu, Karthinathan; Vermersch, Patrick | Journal Contribution | A1 |
| 50 | 2020 | Risk of secondary progressive multiple sclerosis: A longitudinal study | Fambiatos, Adam; Jokubaitis, Vilija; Horakova, Dana; Havrdova, Eva Kubala; Trojano, Maria; Prat, Alexandre; Girard, Marc; Duquette, Pierre; Lugaresi, Alessandra; Izquierdo, Guillermo; Grand'Maison, Francois; Grammond, Pierre; Sola, Patrizia; Ferraro, Diana; Alroughani, Raed; Terzi, Murat; Hupperts, Raymond; Boz, Cavit; Lechner-Scott, Jeannette; Pucci, Eugenio; Bergamaschi, Roberto; Van Pesch, Vincent; Ozakbas, Serkan; Granella, Franco; Turkoglu, Recai; Iuliano, Gerardo; Spitaleri, Daniele; McCombe, Pamela; Solaro, Claudio; Slee, Mark; Ampapa, Radek; Soysal, Aysun; Petersen, Thor; Sanchez-Menoyo, Jose Luis; Verheul, Freek; Prevost, Julie; Sidhom, Youssef; VAN WIJMEERSCH, Bart; Vucic, Steve; Cristiano, Edgardo; Saladino, Maria Laura; Deri, Norma; Barnett, Michael; Olascoaga, Javier; Moore, Fraser; Skibina, Olga; Gray, Orla; Fragoso, Yara; Yamout, Bassem; Shaw, Cameron; Singhal, Bhim; Shuey, Neil; Hodgkinson, Suzanne; Altintas, Ayse; Al-Harbi, Talal; Csepany, Tunde; Taylor, Bruce; Hughes, Jordana; Jun, Jae-Kwan; van der Walt, Anneke; Spelman, Tim; Butzkueven, Helmut; Kalincik, Tomas | Journal Contribution | A1 |
| 51 | 2020 | Deciphering the Morphology of Motor Evoked Potentials | YPERMAN, Jan; BECKER, Thijs; VALKENBORG, Dirk; HELLINGS, Niels; Cambron, M; Dive, D; Laureys, G.; POPESCU, Veronica; VAN WIJMEERSCH, Bart; PEETERS, Liesbet | Journal Contribution | A1 |
| 52 | 2020 | Comparing 16 Different Dual–Tasking Paradigms in Individuals With Multiple Sclerosis and Healthy Controls: Working Memory Tasks Indicate Cognitive–Motor Interference | LEONE, Carmela; MOUMDJIAN, Lousin; Patti, Francesco; VANZEIR, Ellen; BAERT, Ilse; VELDKAMP, Renee; VAN WIJMEERSCH, Bart; FEYS, Peter | Journal Contribution | A1 |
| 53 | 2020 | Machine learning analysis of motor evoked potential time series to predict disability progression in multiple sclerosis | YPERMAN, Jan; BECKER, Thijs; VALKENBORG, Dirk; POPESCU, Veronica; HELLINGS, Niels; VAN WIJMEERSCH, Bart; PEETERS, Liesbet | Journal Contribution | A1 |
Loading...
5
0
5
0
false